Edesa Biotech Inc.

5.18-0.0500-0.96%Vol 60.00K1Y Perf -4.47%
Jul 23rd, 2021 16:00 DELAYED
BID4.85 ASK5.34
Open5.19 Previous Close5.23
Pre-Market- After-Market-
 - -  - -%
Target Price
17.00 
Analyst Rating
Strong Buy 1.00
Potential %
228.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap68.67M 
Earnings Rating
Price Range Ratio 52W %
7.51 
Earnings Date
11th Aug 2021

Today's Price Range

4.975.20

52W Range

4.0519.10

5 Year PE Ratio Range

-5.60-1.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
3.60%
1 Month
-5.65%
3 Months
-7.66%
6 Months
-10.54%
1 Year
-4.47%
3 Years
-48.92%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EDSA5.18-0.0500-0.96
AAPL148.561.76001.20
GOOG2 756.3289.75003.37
MSFT289.673.53001.23
XOM57.04-0.0700-0.12
WFC44.59-0.4400-0.98
JNJ171.791.81001.06
FB369.7918.60005.30
GE12.710.01000.08
JPM150.64-0.2900-0.19
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.30-0.1936.67
Q01 2021-0.19-0.26-36.84
Q04 2020-0.21-0.22-4.76
Q03 2020-0.21-0.204.76
Q02 2020-0.26-0.1734.62
Q01 2020--0.15-
Q04 2019--0.07-
Q03 2019--0.30-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Aug 2021
Estimated EPS Next Report-0.32
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume60.00K
Shares Outstanding13.26M
Trades Count312
Dollar Volume2.43M
Avg. Volume387.05K
Avg. Weekly Volume64.31K
Avg. Monthly Volume45.32K
Avg. Quarterly Volume183.41K

Edesa Biotech Inc. (NASDAQ: EDSA) stock closed at 5.18 per share at the end of the most recent trading day (a -0.96% change compared to the prior day closing price) with a volume of 60.04K shares and market capitalization of 68.67M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 10 people. Edesa Biotech Inc. CEO is Pardeep Nijhawan.

The one-year performance of Edesa Biotech Inc. stock is -4.47%, while year-to-date (YTD) performance is 21.88%. EDSA stock has a five-year performance of %. Its 52-week range is between 4.05 and 19.1, which gives EDSA stock a 52-week price range ratio of 7.51%

Edesa Biotech Inc. currently has a PE ratio of -5.70, a price-to-book (PB) ratio of 3.44, a price-to-sale (PS) ratio of 307.47, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -76.37%, a ROC of -82.21% and a ROE of -84.97%. The company’s profit margin is -%, its EBITDA margin is -1 765.10%, and its revenue ttm is $225.05 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Edesa Biotech Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.32 for the next earnings report. Edesa Biotech Inc.’s next earnings report date is 11th Aug 2021.

The consensus rating of Wall Street analysts for Edesa Biotech Inc. is Strong Buy (1), with a target price of $17, which is +228.19% compared to the current price. The earnings rating for Edesa Biotech Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Edesa Biotech Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Edesa Biotech Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.82, ATR14 : 0.27, CCI20 : -50.65, Chaikin Money Flow : 0.17, MACD : -0.12, Money Flow Index : 44.80, ROC : -0.38, RSI : 44.51, STOCH (14,3) : 59.38, STOCH RSI : 0.75, UO : 57.22, Williams %R : -40.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Edesa Biotech Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
Summary RatingStrong Buy
1.00
Strong Buy
1.00
-

Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

CEO: Pardeep Nijhawan

Telephone: +1 905 475-1234

Address: 100 Spy Court, Markham L3R 5H6, ON, CA

Number of employees: 10

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

48%53%

Bearish Bullish

60%40%

News

Stocktwits